First Trust Advisors LP reduced its stake in Novo Nordisk A/S (NYSE: NVO) by 94.5% during the first

This whale alert can help traders discover the next big trading opportunities. Whales are entities w

Scholar Rock shifts its FDA review for SMA treatment apitegromab to a secondary facility, keeping th

Novo Nordisk A/S NYSE: NVO reported second-quarter adjusted sales growth of 7% at constant exchange

Eli Lilly should request approval for retatrutide early next year. This medicine could help the comp

Novo Nordisk (NVO), the Danish pharmaceutical giant behind Ozempic and Wegovy, edged nearly 2% highe

Novo Nordisk A/S receives a Sell rating due to falling profits, weak revenue growth, and operational

Amazon Pharmacy offers eligible Medicare patients weight-loss drugs for $50 monthly under a new fede

Novo Nordisk recently experienced a clinical setback. Despite financial results mostly in line with

Novo Nordisk A/S delivered a strong Q2, beating revenue by 10% and EPS by over 20%, yet shares dippe

Novo Nordisk lifts its 2026 outlook as Wegovy pill demand accelerates, even as U.S. pricing, patent

A Dutch court has banned sales of an unapproved compounded semaglutide nasal spray following a legal

Both Eli Lilly and Novo Nordisk beat second-quarter estimates and raised their full-year outlooks. B

Bank of America spends over $250 million yearly on GLP-1 drugs, with CEO Brian Moynihan calling it a

Novo Nordisk (NVO), the Danish pharmaceutical giant behind Wegovy and Ozempic, raised its full-year

The Danish company developed the most lucrative new drug the world had ever seen. Then America's Eli

Novo Nordisk beats Q2 earnings and sales estimates as GLP-1 demand grows, but pricing pressure, outl

Novo Nordisk A/S delivered mixed Q2 results with 7% adjusted net sales growth and an upward revision

Danish ​drugmaker Novo ‌Nordisk said on ​Wednesday ​it had won ⁠a ​preliminary injunction ​against C

FTSE 100 up 51 points to 10,931 Oil prices waver as Hormuz deal mooted UK services sector moves into

Chief Executive Mike Doustdar's comments come amid sector focus on M&A and after Novo Nordisk made t

CVS Pharmacy offers all FDA approved GLP-1s, whether through insurance or cash-pay options.New colla

FTSE 100 up 19 points to 10,899 Oil prices waver as Hormuz deal mooted SpaceX's earnings beat runs i

Novo Nordisk hikes its 2026 outlook, but investors focus more on quarterly sales of the Danish pharm

Novo Nordisk raised its full year outlook late Tuesday. Analysts said the better-than-expected quart

Novo Nordisk CEO Mike Doustdar faces investors and analysts on Wednesday under pressure to restore c

Novo Nordisk (NYSE:NVO) reported quarterly earnings of $0.96 per share which beat the analyst consen

The Danish drugmaker also revealed an improved outlook for the year.

US-listed shares of Novo Nordisk fell more than 6% on Tuesday after the Danish drugmaker released it

Novo Nordisk A/S (NYSE:NVO) stock is trading lower on Tuesday despite the company raising its fiscal

Novo Nordisk raises 2026 guidance as Wegovy pill tops 5 million U.S. prescriptions, but stock falls

The Danish drugmaker continues to rely on the success of semaglutide, branded as Wegovy for weight l

U.S.-traded shares of Novo Nordisk dropped more than 5% after the Danish drugmaker released guidance

The Danish drugmaker said annual sales and operating profit should fall less than it previously expe

Novo Nordisk today announced adjusted sales and adjusted operating profit for the second quarter of

Novo Nordisk , the maker of weight-loss drug Wegovy, reported a second-quarter adjusted operating ​p

This whale alert can help traders discover the next big trading opportunities. Whales are entities w

SanDisk, Western Digital and eight other names carry the biggest implied earnings moves in the first

BioAge Labs stock plummeted as failed Phase 3 ZEUS trial data from Novo Nordisk sparked broad concer

Novo Nordisk Phase 3 ZEUS trial shows ziltivekimab missed MACE risk reduction. Operating profit outl

Novo Nordisk today announced headline results from the ZEUS cardiovascular outcomes phase 3 trial.Wh

This whale alert can help traders discover the next big trading opportunities. Whales are entities w

This whale alert can help traders discover the next big trading opportunities. Whales are entities w

This whale alert can help traders discover the next big trading opportunities. Whales are entities w

Eli Lilly and Company (NYSE:LLY), the maker of Zepbound (tirzepatide) and Foundayo (orforglipron), t

Novo Nordisk has filed a lawsuit against Eli Lilly, alleging false advertising and deceptive marketi

Novo Nordisk takes action to stop multiple misleading national GLP-1 advertising campaigns by Eli Li

A weight-loss prescription that runs $149 to $449 a month at the pharmacy counter now costs some Med

Novo Nordisk wins EU approval for Wegovy pill, the first oral GLP-1 for weight management, backed by

Novo Nordisk today announced that the European Commission (EC) has granted marketing authorisation f